Diabetes and COVID-19: IDF perspective in the Western Pacific region.
Identifieur interne : 000225 ( Main/Exploration ); précédent : 000224; suivant : 000226Diabetes and COVID-19: IDF perspective in the Western Pacific region.
Auteurs : Yerin Hwang [Corée du Sud] ; Altaisaikhan Khasag [Mongolie] ; Weiping Jia [République populaire de Chine] ; Alicia Jenkins [Australie] ; Chien-Ning Huang [Taïwan] ; Daisuke Yabe [Japon] ; Doo-Man Kim [Corée du Sud] ; Takashi Kadowaki [Japon] ; Moon-Kyu Lee [Corée du Sud]Source :
- Diabetes research and clinical practice [ 1872-8227 ] ; 2020.
Abstract
The World Health Organization (WHO) declared a pandemic, the highest risk level in the infectious disease alert phase, on 11 March 2020. In the Western Pacific Region (WPR), 192,016 confirmed cases with 7125 deaths had been reported as of 8 June 2020. In people with diabetes COVID-19 can be more difficult to treat due to the wide fluctuations in blood glucose levels or presence of comorbidities such as diabetes complications, including cardiovascular disease and renal damage, which are recognized risks for adverse outcomes. National diabetes associations and governments have established guidelines for subjects with diabetes in relation to COVID-19, and are trying to supply emergency and their regularly required medical products for them. The WPR is so large and composed of such diverse countries and COVID-19 situations, no one conclusion or program applies. Instead we could see a diverse COVID-19 pandemic profile in the WPR, and several creative diagnostic and therapeutic measures undertaken. This includes drive-through screening facilities, high-speed RT-PCR technologies, convalescent patients' plasma therapy, which potentially had some positive contributions in combatting COVID-19 in the WPR as well as globally. Although the numbers of confirmed cases are currently decreasing in the region, the COVID-19 pandemic is not over, and many experts are recommending to prepare measures for potential second or third waves of COVID-19.
DOI: 10.1016/j.diabres.2020.108278
PubMed: 32592842
PubMed Central: PMC7314686
Affiliations:
- Australie, Corée du Sud, Japon, Mongolie, République populaire de Chine, Taïwan
- Nouvelle-Galles du Sud, Région capitale de Séoul, Région de Kantō
- Sydney, Séoul, Tokyo
- Université de Sydney, Université de Tokyo
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Diabetes and COVID-19: IDF perspective in the Western Pacific region.</title><author><name sortKey="Hwang, Yerin" sort="Hwang, Yerin" uniqKey="Hwang Y" first="Yerin" last="Hwang">Yerin Hwang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon</wicri:regionArea><wicri:noRegion>Suwon</wicri:noRegion></affiliation></author><author><name sortKey="Khasag, Altaisaikhan" sort="Khasag, Altaisaikhan" uniqKey="Khasag A" first="Altaisaikhan" last="Khasag">Altaisaikhan Khasag</name><affiliation wicri:level="1"><nlm:affiliation>Health Sciences University of Mongolia, Ulaanbaatar, Mongolia.</nlm:affiliation><country xml:lang="fr">Mongolie</country><wicri:regionArea>Health Sciences University of Mongolia, Ulaanbaatar</wicri:regionArea><wicri:noRegion>Ulaanbaatar</wicri:noRegion></affiliation></author><author><name sortKey="Jia, Weiping" sort="Jia, Weiping" uniqKey="Jia W" first="Weiping" last="Jia">Weiping Jia</name><affiliation wicri:level="1"><nlm:affiliation>Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital</wicri:regionArea><wicri:noRegion>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Jenkins, Alicia" sort="Jenkins, Alicia" uniqKey="Jenkins A" first="Alicia" last="Jenkins">Alicia Jenkins</name><affiliation wicri:level="4"><nlm:affiliation>NHMRC Clinical Trials Center, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>NHMRC Clinical Trials Center, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Huang, Chien Ning" sort="Huang, Chien Ning" uniqKey="Huang C" first="Chien-Ning" last="Huang">Chien-Ning Huang</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shang Medical University Hospital, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shang Medical University Hospital, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Yabe, Daisuke" sort="Yabe, Daisuke" uniqKey="Yabe D" first="Daisuke" last="Yabe">Daisuke Yabe</name><affiliation wicri:level="1"><nlm:affiliation>Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu</wicri:regionArea><wicri:noRegion>Gifu</wicri:noRegion></affiliation></author><author><name sortKey="Kim, Doo Man" sort="Kim, Doo Man" uniqKey="Kim D" first="Doo-Man" last="Kim">Doo-Man Kim</name><affiliation wicri:level="3"><nlm:affiliation>Department of Endocrinology and Metabolism, Hallym University School of Medicine, Seoul, South Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Endocrinology and Metabolism, Hallym University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Kadowaki, Takashi" sort="Kadowaki, Takashi" uniqKey="Kadowaki T" first="Takashi" last="Kadowaki">Takashi Kadowaki</name><affiliation wicri:level="4"><nlm:affiliation>Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Toranomon Hospital, Tokyo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Toranomon Hospital, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName><orgName type="university">Université de Tokyo</orgName></affiliation></author><author><name sortKey="Lee, Moon Kyu" sort="Lee, Moon Kyu" uniqKey="Lee M" first="Moon-Kyu" last="Lee">Moon-Kyu Lee</name><affiliation wicri:level="1"><nlm:affiliation>Division of Endocrinology & Metabolism, Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Republic of Korea. Electronic address: leemk4132@gmail.com.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Division of Endocrinology & Metabolism, Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi</wicri:regionArea><wicri:noRegion>Gumi</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32592842</idno><idno type="pmid">32592842</idno><idno type="doi">10.1016/j.diabres.2020.108278</idno><idno type="pmc">PMC7314686</idno><idno type="wicri:Area/Main/Corpus">000098</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000098</idno><idno type="wicri:Area/Main/Curation">000098</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000098</idno><idno type="wicri:Area/Main/Exploration">000098</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Diabetes and COVID-19: IDF perspective in the Western Pacific region.</title><author><name sortKey="Hwang, Yerin" sort="Hwang, Yerin" uniqKey="Hwang Y" first="Yerin" last="Hwang">Yerin Hwang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon</wicri:regionArea><wicri:noRegion>Suwon</wicri:noRegion></affiliation></author><author><name sortKey="Khasag, Altaisaikhan" sort="Khasag, Altaisaikhan" uniqKey="Khasag A" first="Altaisaikhan" last="Khasag">Altaisaikhan Khasag</name><affiliation wicri:level="1"><nlm:affiliation>Health Sciences University of Mongolia, Ulaanbaatar, Mongolia.</nlm:affiliation><country xml:lang="fr">Mongolie</country><wicri:regionArea>Health Sciences University of Mongolia, Ulaanbaatar</wicri:regionArea><wicri:noRegion>Ulaanbaatar</wicri:noRegion></affiliation></author><author><name sortKey="Jia, Weiping" sort="Jia, Weiping" uniqKey="Jia W" first="Weiping" last="Jia">Weiping Jia</name><affiliation wicri:level="1"><nlm:affiliation>Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital</wicri:regionArea><wicri:noRegion>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Jenkins, Alicia" sort="Jenkins, Alicia" uniqKey="Jenkins A" first="Alicia" last="Jenkins">Alicia Jenkins</name><affiliation wicri:level="4"><nlm:affiliation>NHMRC Clinical Trials Center, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>NHMRC Clinical Trials Center, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Huang, Chien Ning" sort="Huang, Chien Ning" uniqKey="Huang C" first="Chien-Ning" last="Huang">Chien-Ning Huang</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shang Medical University Hospital, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shang Medical University Hospital, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Yabe, Daisuke" sort="Yabe, Daisuke" uniqKey="Yabe D" first="Daisuke" last="Yabe">Daisuke Yabe</name><affiliation wicri:level="1"><nlm:affiliation>Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu</wicri:regionArea><wicri:noRegion>Gifu</wicri:noRegion></affiliation></author><author><name sortKey="Kim, Doo Man" sort="Kim, Doo Man" uniqKey="Kim D" first="Doo-Man" last="Kim">Doo-Man Kim</name><affiliation wicri:level="3"><nlm:affiliation>Department of Endocrinology and Metabolism, Hallym University School of Medicine, Seoul, South Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Endocrinology and Metabolism, Hallym University School of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Kadowaki, Takashi" sort="Kadowaki, Takashi" uniqKey="Kadowaki T" first="Takashi" last="Kadowaki">Takashi Kadowaki</name><affiliation wicri:level="4"><nlm:affiliation>Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Toranomon Hospital, Tokyo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Toranomon Hospital, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName><orgName type="university">Université de Tokyo</orgName></affiliation></author><author><name sortKey="Lee, Moon Kyu" sort="Lee, Moon Kyu" uniqKey="Lee M" first="Moon-Kyu" last="Lee">Moon-Kyu Lee</name><affiliation wicri:level="1"><nlm:affiliation>Division of Endocrinology & Metabolism, Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Republic of Korea. Electronic address: leemk4132@gmail.com.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Division of Endocrinology & Metabolism, Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi</wicri:regionArea><wicri:noRegion>Gumi</wicri:noRegion></affiliation></author></analytic><series><title level="j">Diabetes research and clinical practice</title><idno type="eISSN">1872-8227</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The World Health Organization (WHO) declared a pandemic, the highest risk level in the infectious disease alert phase, on 11 March 2020. In the Western Pacific Region (WPR), 192,016 confirmed cases with 7125 deaths had been reported as of 8 June 2020. In people with diabetes COVID-19 can be more difficult to treat due to the wide fluctuations in blood glucose levels or presence of comorbidities such as diabetes complications, including cardiovascular disease and renal damage, which are recognized risks for adverse outcomes. National diabetes associations and governments have established guidelines for subjects with diabetes in relation to COVID-19, and are trying to supply emergency and their regularly required medical products for them. The WPR is so large and composed of such diverse countries and COVID-19 situations, no one conclusion or program applies. Instead we could see a diverse COVID-19 pandemic profile in the WPR, and several creative diagnostic and therapeutic measures undertaken. This includes drive-through screening facilities, high-speed RT-PCR technologies, convalescent patients' plasma therapy, which potentially had some positive contributions in combatting COVID-19 in the WPR as well as globally. Although the numbers of confirmed cases are currently decreasing in the region, the COVID-19 pandemic is not over, and many experts are recommending to prepare measures for potential second or third waves of COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32592842</PMID><DateRevised><Year>2020</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8227</ISSN><JournalIssue CitedMedium="Internet"><Volume>166</Volume><PubDate><Year>2020</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>Diabetes research and clinical practice</Title><ISOAbbreviation>Diabetes Res. Clin. Pract.</ISOAbbreviation></Journal><ArticleTitle>Diabetes and COVID-19: IDF perspective in the Western Pacific region.</ArticleTitle><Pagination><MedlinePgn>108278</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0168-8227(20)30530-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.diabres.2020.108278</ELocationID><Abstract><AbstractText>The World Health Organization (WHO) declared a pandemic, the highest risk level in the infectious disease alert phase, on 11 March 2020. In the Western Pacific Region (WPR), 192,016 confirmed cases with 7125 deaths had been reported as of 8 June 2020. In people with diabetes COVID-19 can be more difficult to treat due to the wide fluctuations in blood glucose levels or presence of comorbidities such as diabetes complications, including cardiovascular disease and renal damage, which are recognized risks for adverse outcomes. National diabetes associations and governments have established guidelines for subjects with diabetes in relation to COVID-19, and are trying to supply emergency and their regularly required medical products for them. The WPR is so large and composed of such diverse countries and COVID-19 situations, no one conclusion or program applies. Instead we could see a diverse COVID-19 pandemic profile in the WPR, and several creative diagnostic and therapeutic measures undertaken. This includes drive-through screening facilities, high-speed RT-PCR technologies, convalescent patients' plasma therapy, which potentially had some positive contributions in combatting COVID-19 in the WPR as well as globally. Although the numbers of confirmed cases are currently decreasing in the region, the COVID-19 pandemic is not over, and many experts are recommending to prepare measures for potential second or third waves of COVID-19.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Yerin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khasag</LastName><ForeName>Altaisaikhan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Sciences University of Mongolia, Ulaanbaatar, Mongolia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Weiping</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NHMRC Clinical Trials Center, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chien-Ning</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Chung Shang Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yabe</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Doo-Man</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Hallym University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadowaki</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Toranomon Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Moon-Kyu</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Division of Endocrinology & Metabolism, Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Republic of Korea. Electronic address: leemk4132@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Diabetes Res Clin Pract</MedlineTA><NlmUniqueID>8508335</NlmUniqueID><ISSNLinking>0168-8227</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32592842</ArticleId><ArticleId IdType="pii">S0168-8227(20)30530-1</ArticleId><ArticleId IdType="doi">10.1016/j.diabres.2020.108278</ArticleId><ArticleId IdType="pmc">PMC7314686</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Corée du Sud</li><li>Japon</li><li>Mongolie</li><li>République populaire de Chine</li><li>Taïwan</li></country><region><li>Nouvelle-Galles du Sud</li><li>Région capitale de Séoul</li><li>Région de Kantō</li></region><settlement><li>Sydney</li><li>Séoul</li><li>Tokyo</li></settlement><orgName><li>Université de Sydney</li><li>Université de Tokyo</li></orgName></list><tree><country name="Corée du Sud"><noRegion><name sortKey="Hwang, Yerin" sort="Hwang, Yerin" uniqKey="Hwang Y" first="Yerin" last="Hwang">Yerin Hwang</name></noRegion><name sortKey="Kim, Doo Man" sort="Kim, Doo Man" uniqKey="Kim D" first="Doo-Man" last="Kim">Doo-Man Kim</name><name sortKey="Lee, Moon Kyu" sort="Lee, Moon Kyu" uniqKey="Lee M" first="Moon-Kyu" last="Lee">Moon-Kyu Lee</name></country><country name="Mongolie"><noRegion><name sortKey="Khasag, Altaisaikhan" sort="Khasag, Altaisaikhan" uniqKey="Khasag A" first="Altaisaikhan" last="Khasag">Altaisaikhan Khasag</name></noRegion></country><country name="République populaire de Chine"><noRegion><name sortKey="Jia, Weiping" sort="Jia, Weiping" uniqKey="Jia W" first="Weiping" last="Jia">Weiping Jia</name></noRegion></country><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Jenkins, Alicia" sort="Jenkins, Alicia" uniqKey="Jenkins A" first="Alicia" last="Jenkins">Alicia Jenkins</name></region></country><country name="Taïwan"><noRegion><name sortKey="Huang, Chien Ning" sort="Huang, Chien Ning" uniqKey="Huang C" first="Chien-Ning" last="Huang">Chien-Ning Huang</name></noRegion></country><country name="Japon"><noRegion><name sortKey="Yabe, Daisuke" sort="Yabe, Daisuke" uniqKey="Yabe D" first="Daisuke" last="Yabe">Daisuke Yabe</name></noRegion><name sortKey="Kadowaki, Takashi" sort="Kadowaki, Takashi" uniqKey="Kadowaki T" first="Takashi" last="Kadowaki">Takashi Kadowaki</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000225 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000225 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CardioCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32592842
|texte= Diabetes and COVID-19: IDF perspective in the Western Pacific region.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32592842" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CardioCovidV1
| This area was generated with Dilib version V0.6.35. |  |